Trisalus life sciences lays out therapeutic strategy upon acquisition of first therapeutic candidate

Trisalus life sciences announces its therapeutic clinical development strategy following the acquisition of sd-101, from dynavax technologies.

CSTL Ratings Summary

CSTL Quant Ranking